Leteprinim
CAS No. 138117-50-7
Leteprinim ( AIT 082 acid | AIT-082 acid | AIT082 acid )
产品货号. M27992 CAS No. 138117-50-7
Leteprinim 是一种次黄嘌呤衍生物,可刺激体外神经突生长以及星形胶质细胞产生腺苷和神经营养素。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥1026 | 有现货 |
|
| 5MG | ¥1663 | 有现货 |
|
| 10MG | ¥2461 | 有现货 |
|
| 25MG | ¥3832 | 有现货 |
|
| 50MG | ¥5199 | 有现货 |
|
| 100MG | ¥6750 | 有现货 |
|
| 200MG | ¥8883 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Leteprinim
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Leteprinim 是一种次黄嘌呤衍生物,可刺激体外神经突生长以及星形胶质细胞产生腺苷和神经营养素。
-
产品描述Leteprinim is an hypoxanthine derivative that stimulates in vitro neurite outgrowth and the production of adenosine and neurotrophins from astrocytes.(In Vitro):Leteprinim stimulates the outgrowth of neurites from PC12 cells and neurons, stimulates the synthesis and/or release of neurotrophic factors from astrocytes, enhances nerve fibre regeneration in vivo, and enhances memory in animals and humans. Leteprinim also protects against glutamate neurotoxicity in vitro and in vivo, which has led to successful tests of Leteprinim in animal models of acute central nervous system injury.(In Vivo):Leteprinim (60 mg/kg/day; i.p., for 7 days, starting from 20 min before the kainate injection) did not modify the seizures caused by kainate but, like diazepam, it decreased kainate-induced mortality, the reduction of GAD activity, and the loss of hippocampal neurons in rats.
-
体外实验——
-
体内实验——
-
同义词AIT 082 acid | AIT-082 acid | AIT082 acid
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number138117-50-7
-
分子量327.3
-
分子式C15H13N5O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)c1ccc(NC(=O)CCn2cnc3c2nc[nH]c3=O)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.BURSTEIN CL. Benzquinamide:cardiovascular stimulant useful during general anesthesia. Anesth Analg. 1963 Jul-Aug;42:429-34.
产品手册
关联产品
-
Gambogellic acid
Gambogellic acid antitumor activity. is an xanthone isolated from the processed gamboge.
-
ZINC77292789
Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 是一种试剂,用于制备带有 βGalNAc-?Thr 的合成 MUC1 糖肽,作为 Tn 抗原异构体,诱导针对肿瘤细胞的抗体产生。 Fmoc-Thr[GalNAc(Ac)3-α-D]-OH 是制造基于三聚体 MUC1 免疫显性基序抗原的抗癌疫苗候选物的起始材料。
-
MRT-2359
MRT-2359 是一种口服有效的 GSPT1 降解剂 (IC50: >30 nM 且 <300 nM) ,具有抗肿瘤活性。MRT-2359 还抑制耐药非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 细胞的生长。MRT-2359 在 MYC 驱动的细胞系中表现出优先活性,例如 N-和 L-MYC 高 NSCLC 和 SCLC 患者来源的异种移植物 (PDX)。
021-51111890
购物车()
sales@molnova.cn

